HEMODYNAMIC SAFETY OF CONTINUOUS-INFUSION LABETALOL VERSUS ESMOLOL-BASED THERAPY FOR TBADS

被引：0
作者：
Hoogendoorn, Kayla [1 ]
Mahmoud, Ahmed [1 ]
Leong, Christopher [1 ]
机构：
[1] Midwestern Univ COP, Downers Grove, IL USA
来源：
CRITICAL CARE MEDICINE | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
226
引用
收藏
页数：1
相关论文
共 50 条
  • [1] HEMODYNAMIC SAFETY OF CONTINUOUS-INFUSION LABETALOL VERSUS ESMOLOL-BASED THERAPY FOR TBADS
    Hoogendoorn, Kayla
    Mahmoud, Ahmed
    Leong, Christopher
    CRITICAL CARE MEDICINE, 2019, 47
  • [2] Hemodynamic Safety of Continuous Infusion Labetalol Versus Esmolol Combination Therapies for Type B Aortic Dissections
    Myers, Kayla L.
    Leong, Christopher R.
    Mahmoud, Ahmed A.
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (06) : 870 - 874
  • [3] Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients
    Hecht, Jason P.
    Richards, Patrick G.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (02) : 460 - 465
  • [4] Efficacy and Safety of Extended Continuous-Infusion Neostigmine
    Foris, L.
    Samad, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [5] HEMODYNAMIC RESPONSE IN HIGH VERSUS LOW SHOCK INDEX PATIENTS RECEIVING CONTINUOUS-INFUSION KETAMINE
    Thomas, Divya
    Ernst, Neil
    Mueller, Eric
    Droege, Christopher
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 435 - 435
  • [6] HEMODYNAMIC EFFECTS OF CONTINUOUS-INFUSION DEXMEDETOMIDINE AND KETAMINE IN SEPTIC SHOCK
    Piatka, Corissa
    Bradshaw, Paige
    Hammond, Drayton
    Mueller, Eric
    Winter, Jessica
    Droege, Christopher
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 642 - 642
  • [7] BRADYCARDIA DURING CONTINUOUS-INFUSION AMINOPHYLLINE THERAPY
    STEMPEL, DA
    LEWISTON, NJ
    CLINICAL RESEARCH, 1977, 25 (02): : A194 - A194
  • [8] Comparative doses and cost: Esmolol versus labetalol during electroconvulsive therapy
    Drop, L
    Castelli, I
    Kaufmann, M
    ANESTHESIA AND ANALGESIA, 1998, 86 (04) : 916 - 917
  • [9] PHASE-I TRIAL OF COMBINATION THERAPY WITH CONTINUOUS-INFUSION MMPR AND CONTINUOUS-INFUSION 5-FU
    PETERS, WP
    WEISS, G
    KUFE, DW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (02) : 136 - 138
  • [10] A PHASE-I TRIAL OF COMBINATION THERAPY WITH CONTINUOUS-INFUSION PALA AND CONTINUOUS-INFUSION 5-FU
    WEISS, GR
    ERVIN, TJ
    MESHAD, MW
    SCHADE, D
    BRANFMAN, AR
    BRUNI, RJ
    CHADWICK, M
    KUFE, DW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (03) : 301 - 304
12345